| Category: |
Antibody |
| Concentration: |
pH7, with 0, 02% sodium azide, 3, 5 mg/ml in 1X TBS, 5% BSA (US sourced) and 0 |
| Form: |
Antigen affinity purified |
| Conjugation: |
Unconjugated |
| Clone: |
Polyclonal antibody |
| Recognised antigen: |
SFRP2 |
| Host animal: |
Goat (Capra aegagrus hircus) |
| Clonality: |
Polyclonal (goat origin) |
| Species reactivity: |
Due to limited knowledge and inability to test the antibody against all known species, we cannot guarantee that no other cross reactivity can occur, Human (Homo sapiens) |
| Tested applications: |
ELISA (peptide), WB |
| Recommended dilutions: |
ELISA (peptide) LOD: 1:32000, Western blot: 1-3ug/ml |
| Notes: |
Optimal dilution of the SFRP2 antibody should be determined by the researcher |
| Intented use: |
This SFRP2 antibodyis to be used only for research purposes and not for diagnostics |
| Gene ID #: |
6423 |
| Purity: |
Antigen affinity |
| Description: |
Additional name(s) for this target protein: Secreted frizzled-related protein 2 |
| Immunogen: |
Amino acids KRWQKGQREFKR were used as the immunogen for this SFRP2 antibody |
| Storage: |
Celcius or lower, Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity, Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized, Aliquot and store the SFRP2 antibody at -20 deg |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24° |
| Gene target: |
SFRP2 |
| Short name: |
SFRP2 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
secreted frizzled-related protein 2 (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
DNA-templated and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0046546 and development of primary male sexual characteristics and biological process this GO :0048018 and receptor a this GO nist activity and molecular function this GO :0048546 and digestive tract morphogenesis and biological process this GO :0050680 and negative regulation of epithelial cell proliferation and biological process this GO :0050732 and negative regulation of peptidyl-tyrosine phosphorylation and biological process this GO :0051216 and cartilage development and biological process this GO :0060028 and convergent extension involved in axis elongation and biological process this GO :0060349 and bone morphogenesis and biological process this GO :0061056 and sclerotome development and biological process this GO :0061133 and endopeptidase activator activity and molecular function this GO :0061185 and negative regulation of dermatome development and biological process this GO :0071425 and hematopoietic stem cell proliferation and biological process this GO :0071481 and cellular response to X-ray and biological process this GO :0090090 and negative regulation of canonical Wnt signaling pathway and biological process this GO :0090175 and regulation of establishment of planar polarity and biological process this GO :0090179 and planar cell polarity pathway involved in neural tube closure and biological process this GO :0090244 and Wnt signaling pathway involved in somitogenesis and biological process this GO :0090263 and positive regulation of canonical Wnt signaling pathway and biological process this GO :1902042 and negative regulation of extrinsic apoptotic signaling pathway via death domain receptors and biological process this GO :1902230 and negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage and biological process this GO :2000035 and regulation of stem cell division and biological process this GO :2000041 and negative regulation of planar cell polarity pathway involved in axis elongation and biological process, Extracellular, FRP-2 and SARP1 and SDF-5, SFRP2 and IDBG-41862 and ENSG00000145423 and 6423, SFRP2 and IDBG-629019 and ENSBTAG00000018563 and 510821, Sfrp2 and IDBG-154791 and ENSMUSG00000027996 and 20319, endopeptidase activator activity, this GO :0001569 and patterning of blood vessels and biological process this GO :0001756 and somitogenesis and biological process this GO :0001843 and neural tube closure and biological process this GO :0001944 and vasculature development and biological process this GO :0001968 and fibronectin binding and molecular function this GO :0002063 and chondrocyte development and biological process this GO :0003151 and outflow tract morphogenesis and biological process this GO :0003214 and cardiac left ventricle morphogenesis and biological process this GO :0005178 and integrin binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005615 and extracellular space and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006915 and apoptotic process and biological process this GO :0007267 and cell-cell signaling and biological process this GO :0007420 and brain development and biological process this GO :0007584 and response to nutrient and biological process this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0008285 and negative regulation of cell proliferation and biological process this GO :0008406 and this GO nad development and biological process this GO :0008584 and male this GO nad development and biological process this GO :0009952 and anterior/posterior pattern specification and biological process this GO :0010577 and metalloenzyme activator activity and molecular function this GO :0010629 and negative regulation of gene expression and biological process this GO :0010667 and negative regulation of cardiac muscle cell apoptotic process and biological process this GO :0010719 and negative regulation of epithelial to mesenchymal transition and biological process this GO :0010950 and positive regulation of endopeptidase activity and biological process this GO :0017147 and Wnt-protein binding and molecular function this GO :0021915 and neural tube development and biological process this GO :0030111 and regulation of Wnt signaling pathway and biological process this GO :0030165 and PDZ domain binding and molecular function this GO :0030178 and negative regulation of Wnt signaling pathway and biological process this GO :0030199 and collagen fibril organization and biological process this GO :0030307 and positive regulation of cell growth and biological process this GO :0030308 and negative regulation of cell growth and biological process this GO :0030336 and negative regulation of cell migration and biological process this GO :0030514 and negative regulation of BMP signaling pathway and biological process this GO :0031012 and extracellular matrix and cellular component this GO :0031668 and cellular response to extracellular stimulus and biological process this GO :0033138 and positive regulation of peptidyl-serine phosphorylation and biological process this GO :0033630 and positive regulation of cell adhesion mediated by integrin and biological process this GO :0035413 and positive regulation of catenin import into nucleus and biological process this GO :0036342 and post-anal tail morphogenesis and biological process this GO :0042127 and regulation of cell proliferation and biological process this GO :0042493 and response to drug and biological process this GO :0042662 and negative regulation of mesodermal cell fate specification and biological process this GO :0042733 and embryonic digit morphogenesis and biological process this GO :0042813 and Wnt-activated receptor activity and molecular function this GO :0042981 and regulation of apoptotic process and biological process this GO :0043065 and positive regulation of apoptotic process and biological process this GO :0043154 and negative regulation of cysteine-type endopeptidase activity involved in apoptotic process and biological process this GO :0043508 and negative regulation of JUN kinase activity and biological process this GO :0045600 and positive regulation of fat cell differentiation and biological process this GO :0045669 and positive regulation of osteoblast differentiation and biological process this GO :0045766 and positive regulation of angiogenesis and biological process this GO :0045892 and negative regulation of transcription, this GO :0001968 : fibronectin binding, this GO :0001968 : fibronectin binding and also this GO :0005178 : integrin binding and also this GO :0005515 : protein binding and also this GO :0010577 : metalloenzyme activator activity and also this GO :0017147 : Wnt-protein binding and also this GO :0030165 : PDZ domain binding and also this GO :0042813 : Wnt-activated receptor activity and also this GO :0048018 : receptor a this GO nist activity and also this GO :0061133 : endopeptidase activator activity, this GO :0005178 : integrin binding, this GO :0005515 : protein binding, this GO :0010577 : metalloenzyme activator activity, this GO :0017147 : Wnt-protein binding, this GO :0030165 : PDZ domain binding, this GO :0042813 : Wnt-activated receptor activity, this GO :0048018 : receptor a this GO nist activity, this GO :0061133 : endopeptidase activator activity, secreted frizzled-related protein 2 |
| Identity: |
10777 |
| Gene: |
SFRP2 |
More about : SFRP2 |
| Long gene name: |
secreted frizzled related protein 2 |
| Synonyms: |
SARP1 SDF-5 FRP-2 |
| Locus: |
4q31, 3 |
| Discovery year: |
1998-07-15 |
| GenBank acession: |
AF017986 |
| Entrez gene record: |
6423 |
| Pubmed identfication: |
9391078 |
| Classification: |
Secreted frizzled-related proteins |
| Havana BLAST/BLAT: |
OTTHUMG00000161559 |